rts logo

Who are the Institutional Holders in Petros Pharmaceuticals Inc (PTPI)?

Petros Pharmaceuticals Inc (NASDAQ: PTPI) is -34.04% lower on its value in year-to-date trading and has touched a low of $0.92 and a high of $9.54 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PTPI stock was last observed hovering at around $1.07 in the last trading session, with the day’s loss setting it -0.14%.

Currently trading at $0.93, the stock is -36.90% and -34.76% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.31 million and changing -13.08% at the moment leaves the stock -50.41% off its SMA200. PTPI registered -33.33% loss for a year compared to 6-month loss of -52.31%. The firm has a 50-day simple moving average (SMA 50) of -$0.99 and a 200-day simple moving average (SMA200) of $0.79.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


The stock witnessed a -42.94% gain in the last 1 month and extending the period to 3 months gives it a -34.51%, and is -40.00% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.61% over the week and 9.83% over the month.

Petros Pharmaceuticals Inc (PTPI) has around 21 employees, a market worth around $2.05M and $6.98M in sales. Profit margin for the company is -186.72%. Distance from 52-week low is 1.40% and -90.25% from its 52-week high. The company has generated returns on investments over the last 12 months (-90.21%).

Petros Pharmaceuticals Inc quarterly earnings per share for the current quarter are estimated at -$1.11 with sales reaching $1.55M over the same period.The EPS is expected to grow by 8.10% this year

17 institutions hold shares in Petros Pharmaceuticals Inc (PTPI), with institutional investors hold 8.40% of the company’s shares. The shares outstanding are 2.99M, and float is at 1.31M with Short Float at 6.75%. Institutions hold 5.30% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 31811.0 shares valued at $64576.0. The investor’s holdings represent 1.51% of the PTPI Shares outstanding. As of Jun 29, 2023, the second largest holder is Schonfeld Strategic Advisors Llc with 23200.0 shares valued at $47096.0 to account for 1.10% of the shares outstanding. The other top investors are Renaissance Technologies, LLC which holds 16779.0 shares representing 0.79% and valued at over $34061.0, while Blackrock Inc. holds 0.78% of the shares totaling 16510.0 with a market value of $33515.0.

Related Posts